Stoke Therapeutics and Biogen Report 4-Year Data Supporting Zorevunersen’s Potential in Dravet Syndrome
Bedford, Massachusetts, USA September 3, 2026 Stoke Therapeutics and Biogen have presented new long-term clinical data supporting the potential...
